Skip to content Skip to sidebar Skip to footer
New  million study aims to understand cardiovascular and kidney disease risk factors in women

New $15 million study aims to understand cardiovascular and kidney disease risk factors in women

Research teams from Augusta University, Massachusetts General Hospital and The Ohio State University will lead a $15 million project dedicated to studying the various ways that risk factors for cardiovascular and kidney diseases impact women. The American Heart Association's Strategically Focused Research Network (SFRN) on Cardiovascular Kidney Metabolic Syndrome: Heterogeneity in Women aims to learn why women…

Read more

Gut microbiome pattern predicts future heart attack risk in coronary heart disease patients

Gut microbiome pattern predicts future heart attack risk in coronary heart disease patients

Scientists have identified a gut microbiota profile that can help forecast future cardiovascular events in patients with heart disease, paving the way for more personalized treatment and early interventions. Study:  A microbiota pattern associated with cardiovascular events in secondary prevention: the CORDIOPREV study . Image Credit: Shutterstock AI Generator /…

Read more

Study explores how Adapted Argentine tango dance therapy can help breast cancer survivors

Study explores how Adapted Argentine tango dance therapy can help breast cancer survivors

Adapted Argentine tango dance therapy is helping some breast cancer survivors regain natural balance and sensation after experiencing neuropathy, a common side effect of chemotherapy treatment. Expansion of a new clinical study will look further at how this musical movement intervention can "rewire" the brain to improve function after chemotherapy-related nerve changes.  Lise Worthen-Chaudhari, PhD…

Read more

Promising findings for the treatment of patients with pulmonary arterial hypertension with a high risk of mortality

Promising findings for the treatment of patients with pulmonary arterial hypertension with a high risk of mortality

Pulmonary arterial hypertension (PAH) is a rare and severe lung disease with a life-threatening prognosis. After several positive trials, a recent study has confirmed the efficacy of a biotherapy, sotatercept. These promising results for patients were presented at the American College of Cardiology 2025 Annual Scientific Session (ACC.25) by Marc Humbert, professor at Université Paris-Saclay, head…

Read more

the Kick-ass Multipurpose WordPress Theme

© 2025 Kicker. All Rights Reserved.